Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 60 | 2024 | 1084 | 5.350 |
Why?
|
| Heart Failure | 45 | 2024 | 2387 | 3.110 |
Why?
|
| Heart Transplantation | 13 | 2024 | 875 | 1.260 |
Why?
|
| Prosthesis Implantation | 10 | 2024 | 153 | 0.980 |
Why?
|
| Ventricular Function, Left | 7 | 2024 | 545 | 0.760 |
Why?
|
| Shock, Cardiogenic | 8 | 2022 | 213 | 0.690 |
Why?
|
| Thrombosis | 2 | 2022 | 529 | 0.650 |
Why?
|
| Heart Valve Prosthesis Implantation | 5 | 2022 | 462 | 0.570 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 569 | 0.540 |
Why?
|
| Heart Ventricles | 10 | 2021 | 781 | 0.480 |
Why?
|
| Retrospective Studies | 39 | 2024 | 17371 | 0.480 |
Why?
|
| Tissue and Organ Procurement | 3 | 2023 | 247 | 0.430 |
Why?
|
| Treatment Outcome | 29 | 2024 | 13020 | 0.410 |
Why?
|
| Waiting Lists | 4 | 2023 | 236 | 0.400 |
Why?
|
| Postoperative Complications | 8 | 2020 | 3140 | 0.400 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2021 | 374 | 0.380 |
Why?
|
| Middle Aged | 41 | 2024 | 28895 | 0.360 |
Why?
|
| Humans | 78 | 2024 | 132373 | 0.360 |
Why?
|
| Percutaneous Coronary Intervention | 3 | 2022 | 304 | 0.350 |
Why?
|
| Vascular Resistance | 2 | 2024 | 194 | 0.340 |
Why?
|
| Pulmonary Artery | 3 | 2024 | 462 | 0.330 |
Why?
|
| Hemodynamics | 7 | 2021 | 860 | 0.330 |
Why?
|
| Device Removal | 4 | 2021 | 225 | 0.320 |
Why?
|
| Aortic Valve Insufficiency | 3 | 2019 | 157 | 0.310 |
Why?
|
| Thoracic Surgical Procedures | 2 | 2023 | 107 | 0.300 |
Why?
|
| Tachycardia, Ventricular | 2 | 2024 | 206 | 0.290 |
Why?
|
| Aged | 29 | 2024 | 21386 | 0.290 |
Why?
|
| Catheter Ablation | 2 | 2024 | 241 | 0.290 |
Why?
|
| Male | 49 | 2024 | 65072 | 0.280 |
Why?
|
| Incidental Findings | 1 | 2009 | 130 | 0.280 |
Why?
|
| Heart, Artificial | 2 | 2018 | 69 | 0.260 |
Why?
|
| Time Factors | 15 | 2024 | 6457 | 0.260 |
Why?
|
| Myocarditis | 2 | 2018 | 130 | 0.250 |
Why?
|
| Angioplasty, Balloon, Coronary | 5 | 2009 | 182 | 0.240 |
Why?
|
| Aorta | 2 | 2020 | 554 | 0.230 |
Why?
|
| Registries | 6 | 2022 | 1586 | 0.230 |
Why?
|
| Heart Defects, Congenital | 3 | 2024 | 1868 | 0.230 |
Why?
|
| Female | 45 | 2024 | 70809 | 0.230 |
Why?
|
| Heart Valve Diseases | 2 | 2019 | 178 | 0.220 |
Why?
|
| Physicians | 2 | 2024 | 635 | 0.220 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2021 | 659 | 0.220 |
Why?
|
| Multiple Organ Failure | 1 | 2006 | 145 | 0.220 |
Why?
|
| Acute Kidney Injury | 3 | 2022 | 667 | 0.220 |
Why?
|
| Cardiomyopathies | 2 | 2021 | 508 | 0.220 |
Why?
|
| Aorta, Thoracic | 1 | 2009 | 540 | 0.210 |
Why?
|
| Survival Rate | 9 | 2020 | 2187 | 0.210 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2020 | 1166 | 0.190 |
Why?
|
| Adult | 23 | 2024 | 31624 | 0.190 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2024 | 185 | 0.190 |
Why?
|
| Equipment Failure | 3 | 2018 | 133 | 0.190 |
Why?
|
| Kidney | 3 | 2024 | 1331 | 0.190 |
Why?
|
| Aortic Valve Stenosis | 1 | 2006 | 378 | 0.180 |
Why?
|
| Hyponatremia | 1 | 2022 | 74 | 0.180 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2020 | 237 | 0.170 |
Why?
|
| Aortic Valve | 4 | 2013 | 485 | 0.170 |
Why?
|
| Glucosides | 1 | 2021 | 48 | 0.170 |
Why?
|
| Proportional Hazards Models | 6 | 2020 | 1451 | 0.170 |
Why?
|
| Tissue Donors | 2 | 2023 | 508 | 0.170 |
Why?
|
| Anticoagulants | 2 | 2022 | 607 | 0.170 |
Why?
|
| Benzhydryl Compounds | 1 | 2021 | 68 | 0.160 |
Why?
|
| Health Literacy | 1 | 2021 | 78 | 0.160 |
Why?
|
| Nephrology | 1 | 2022 | 156 | 0.160 |
Why?
|
| Severity of Illness Index | 4 | 2024 | 3088 | 0.160 |
Why?
|
| Risk Factors | 13 | 2024 | 10912 | 0.160 |
Why?
|
| Plasmapheresis | 1 | 2019 | 33 | 0.160 |
Why?
|
| Heart Arrest, Induced | 1 | 2020 | 77 | 0.160 |
Why?
|
| Cause of Death | 2 | 2018 | 503 | 0.150 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 157 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2024 | 1126 | 0.150 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2019 | 16 | 0.150 |
Why?
|
| Patient Selection | 2 | 2020 | 730 | 0.150 |
Why?
|
| Heart Valves | 1 | 2019 | 52 | 0.150 |
Why?
|
| Prosthesis Failure | 2 | 2017 | 162 | 0.150 |
Why?
|
| Survival Analysis | 5 | 2022 | 1570 | 0.150 |
Why?
|
| Transducers, Pressure | 1 | 2018 | 11 | 0.150 |
Why?
|
| Blood Pressure Monitors | 1 | 2018 | 5 | 0.150 |
Why?
|
| Hypoalbuminemia | 1 | 2018 | 16 | 0.150 |
Why?
|
| Incidence | 7 | 2020 | 3362 | 0.150 |
Why?
|
| Transplant Recipients | 1 | 2020 | 225 | 0.140 |
Why?
|
| Renal Insufficiency | 1 | 2021 | 253 | 0.140 |
Why?
|
| Heparin | 1 | 2019 | 214 | 0.140 |
Why?
|
| Myocardial Ischemia | 1 | 2021 | 341 | 0.140 |
Why?
|
| Heart | 1 | 2023 | 699 | 0.140 |
Why?
|
| Arterial Switch Operation | 1 | 2018 | 25 | 0.140 |
Why?
|
| Serum Albumin | 1 | 2018 | 114 | 0.140 |
Why?
|
| Ventricular Function | 2 | 2019 | 91 | 0.140 |
Why?
|
| International Normalized Ratio | 1 | 2018 | 43 | 0.140 |
Why?
|
| Sternotomy | 1 | 2018 | 43 | 0.140 |
Why?
|
| Organ Transplantation | 1 | 2020 | 181 | 0.140 |
Why?
|
| Thrombocytopenia | 1 | 2019 | 234 | 0.140 |
Why?
|
| Prealbumin | 1 | 2017 | 26 | 0.140 |
Why?
|
| Obesity | 3 | 2018 | 2406 | 0.140 |
Why?
|
| Decision Making | 2 | 2024 | 693 | 0.140 |
Why?
|
| Nervous System Diseases | 2 | 2018 | 410 | 0.140 |
Why?
|
| Body Size | 1 | 2017 | 69 | 0.130 |
Why?
|
| Prosthesis-Related Infections | 1 | 2019 | 187 | 0.130 |
Why?
|
| Reoperation | 1 | 2020 | 853 | 0.130 |
Why?
|
| Nutritional Status | 1 | 2018 | 329 | 0.120 |
Why?
|
| Cardiology | 1 | 2021 | 497 | 0.120 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 233 | 0.120 |
Why?
|
| Eosinophilia | 1 | 2017 | 106 | 0.120 |
Why?
|
| Informed Consent | 1 | 2018 | 346 | 0.120 |
Why?
|
| End Stage Liver Disease | 1 | 2018 | 191 | 0.120 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 311 | 0.120 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2017 | 215 | 0.120 |
Why?
|
| Texas | 6 | 2019 | 3629 | 0.110 |
Why?
|
| Malnutrition | 1 | 2017 | 221 | 0.110 |
Why?
|
| Equipment Design | 5 | 2021 | 605 | 0.110 |
Why?
|
| Cell-Derived Microparticles | 1 | 2014 | 29 | 0.110 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2017 | 471 | 0.110 |
Why?
|
| Transposition of Great Vessels | 1 | 2015 | 135 | 0.100 |
Why?
|
| Coronary Thrombosis | 1 | 2013 | 35 | 0.100 |
Why?
|
| Risk Assessment | 6 | 2024 | 3710 | 0.100 |
Why?
|
| Antithrombins | 1 | 2013 | 52 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1188 | 0.100 |
Why?
|
| Fontan Procedure | 1 | 2015 | 190 | 0.090 |
Why?
|
| Prognosis | 5 | 2021 | 5010 | 0.090 |
Why?
|
| Recovery of Function | 3 | 2019 | 461 | 0.090 |
Why?
|
| Young Adult | 7 | 2024 | 9949 | 0.090 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 415 | 0.090 |
Why?
|
| Follow-Up Studies | 5 | 2024 | 5405 | 0.090 |
Why?
|
| Robotics | 2 | 1992 | 108 | 0.090 |
Why?
|
| Atrial Fibrillation | 1 | 2018 | 697 | 0.090 |
Why?
|
| Aortography | 2 | 2009 | 183 | 0.090 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2009 | 165 | 0.090 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2012 | 158 | 0.080 |
Why?
|
| Wounds and Injuries | 1 | 2013 | 392 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2013 | 799 | 0.080 |
Why?
|
| United States | 6 | 2023 | 11631 | 0.080 |
Why?
|
| Prosthesis Design | 3 | 2018 | 669 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2009 | 390 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 2062 | 0.070 |
Why?
|
| Preoperative Period | 2 | 2018 | 92 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 237 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2024 | 1230 | 0.060 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 2022 | 48 | 0.060 |
Why?
|
| Echocardiography | 4 | 2017 | 1125 | 0.060 |
Why?
|
| Takayasu Arteritis | 1 | 2006 | 14 | 0.060 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2006 | 19 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 1061 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 2169 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 1992 | 1807 | 0.060 |
Why?
|
| Coronary Stenosis | 1 | 2006 | 83 | 0.060 |
Why?
|
| Attitude | 1 | 2024 | 120 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 1443 | 0.050 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2024 | 79 | 0.050 |
Why?
|
| Policy | 1 | 2023 | 37 | 0.050 |
Why?
|
| Phenylephrine | 1 | 2022 | 40 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 2303 | 0.050 |
Why?
|
| Stents | 2 | 2006 | 873 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2006 | 679 | 0.050 |
Why?
|
| Logistic Models | 2 | 2018 | 1840 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 311 | 0.050 |
Why?
|
| Cardiac Tamponade | 1 | 2002 | 38 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 892 | 0.050 |
Why?
|
| Pharmacogenomic Testing | 1 | 2021 | 45 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2018 | 377 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2022 | 6540 | 0.040 |
Why?
|
| Tracheostomy | 1 | 2023 | 201 | 0.040 |
Why?
|
| Heart Neoplasms | 1 | 2002 | 104 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2024 | 460 | 0.040 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 2 | 1990 | 35 | 0.040 |
Why?
|
| Pharmacogenetics | 1 | 2021 | 200 | 0.040 |
Why?
|
| Constriction | 1 | 2020 | 47 | 0.040 |
Why?
|
| Sex Factors | 1 | 2024 | 1350 | 0.040 |
Why?
|
| Arteriovenous Malformations | 1 | 2020 | 47 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 7112 | 0.040 |
Why?
|
| Motivation | 1 | 2021 | 329 | 0.040 |
Why?
|
| Diastole | 1 | 2019 | 179 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2023 | 1077 | 0.040 |
Why?
|
| Biomarkers | 2 | 2018 | 3391 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2018 | 1707 | 0.030 |
Why?
|
| Ventricular Function, Right | 1 | 2018 | 119 | 0.030 |
Why?
|
| Base Sequence | 5 | 1994 | 2904 | 0.030 |
Why?
|
| Adolescent | 3 | 2024 | 20560 | 0.030 |
Why?
|
| Punctures | 1 | 2017 | 62 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1649 | 0.030 |
Why?
|
| Comorbidity | 2 | 2016 | 1605 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2018 | 152 | 0.030 |
Why?
|
| Molecular Sequence Data | 5 | 1994 | 3780 | 0.030 |
Why?
|
| Morbidity | 1 | 2017 | 255 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 332 | 0.030 |
Why?
|
| Heart Valve Prosthesis | 1 | 2019 | 331 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2022 | 889 | 0.030 |
Why?
|
| Deoxyribonucleotides | 1 | 1994 | 9 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2021 | 1098 | 0.030 |
Why?
|
| Melanoma | 1 | 2002 | 954 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 3853 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 1992 | 1556 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2015 | 364 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1991 | 357 | 0.030 |
Why?
|
| Hirudins | 1 | 2013 | 36 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2018 | 464 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 1289 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 585 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 1297 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 956 | 0.020 |
Why?
|
| Bacteriophage M13 | 1 | 1992 | 18 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1992 | 46 | 0.020 |
Why?
|
| Myocardium | 1 | 2017 | 908 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 3745 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 1991 | 109 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 806 | 0.020 |
Why?
|
| DNA | 2 | 1994 | 1484 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2014 | 1256 | 0.020 |
Why?
|
| Quality of Life | 1 | 2021 | 2152 | 0.020 |
Why?
|
| Exons | 2 | 1990 | 803 | 0.020 |
Why?
|
| Lesch-Nyhan Syndrome | 1 | 1990 | 11 | 0.020 |
Why?
|
| Nucleotide Mapping | 1 | 1990 | 12 | 0.020 |
Why?
|
| DNA, Viral | 1 | 1992 | 492 | 0.020 |
Why?
|
| Stroke | 1 | 2018 | 1068 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1357 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 1454 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1991 | 1098 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 5153 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 1991 | 804 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1990 | 657 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2009 | 534 | 0.020 |
Why?
|
| Ventricular Dysfunction | 1 | 2006 | 25 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2009 | 831 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2006 | 89 | 0.020 |
Why?
|
| Subclavian Artery | 1 | 2006 | 70 | 0.010 |
Why?
|
| Genome, Human | 1 | 1991 | 1332 | 0.010 |
Why?
|
| Fluoroscopy | 1 | 2005 | 100 | 0.010 |
Why?
|
| Sheep | 1 | 2005 | 229 | 0.010 |
Why?
|
| Myocardial Revascularization | 1 | 2004 | 105 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2006 | 484 | 0.010 |
Why?
|
| Child | 1 | 2022 | 25835 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2008 | 1373 | 0.010 |
Why?
|
| Pericardial Effusion | 1 | 2002 | 71 | 0.010 |
Why?
|
| Genes | 2 | 1990 | 314 | 0.010 |
Why?
|
| Heart Atria | 1 | 2002 | 333 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2002 | 990 | 0.010 |
Why?
|
| Templates, Genetic | 1 | 1994 | 56 | 0.010 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1994 | 92 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 4695 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1994 | 322 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1994 | 352 | 0.010 |
Why?
|
| Fluorescence | 1 | 1991 | 103 | 0.010 |
Why?
|
| Chromosomes, Human | 1 | 1991 | 130 | 0.010 |
Why?
|
| X Chromosome | 1 | 1991 | 340 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1990 | 72 | 0.010 |
Why?
|
| Fluorometry | 1 | 1990 | 26 | 0.010 |
Why?
|
| Genetic Carrier Screening | 1 | 1990 | 72 | 0.010 |
Why?
|
| Automation | 1 | 1990 | 63 | 0.010 |
Why?
|
| Heterozygote | 1 | 1991 | 717 | 0.000 |
Why?
|
| Pedigree | 1 | 1990 | 1725 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1990 | 2673 | 0.000 |
Why?
|
| Software | 1 | 1990 | 729 | 0.000 |
Why?
|
| Animals | 1 | 2005 | 34996 | 0.000 |
Why?
|